4/A//SEC Filing
Oki Mark K 4/A
Accession 0001567619-22-020920
CIK 0001385818other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
4.8 KB
Accession
0001567619-22-020920
Insider Transaction Report
Form 4/AAmended
Oki Mark K
Chief Financial Officer
Transactions
- Purchase
Common Shares
2022-11-18$0.23/sh+90,000$20,700→ 190,000 total
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001491847
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:30 PM ET
- Size
- 4.8 KB